A large population-based cohort study reports that using GLP-1 RAs significantly reduces the risk for cardiovascular events ...

From hot dogs and potato chips to chicken nuggets and sugary sodas, Americans are eating more ultra-processed foods (UPFs) ...

Non-communicable diseases such as diabetes, hypertension and cardiovascular conditions account for over 70% of global deaths ...

Type 2 diabetes is a chronic disease linked to severe health complications, including cardiovascular diseases and increased mortality. While genetics, obesity, and lifestyle factors are known risk ...

Metformin is the most commonly prescribed oral drug for diabetes. Of course, if you or a loved one receives treatment for ...

Martin Holst Lange, Executive Vice President, Development, Novo Nordisk, highlighted during the press briefing that their ...

Diabetes threatens more than just blood sugar levels - discover the major body systems at risk and how to recognize warning ...

A widely used diabetes medication, SGLT2 inhibitors, has shown a surprising benefit for cancer patients—protecting their ...

Heart disease is a silent epidemic that is having a disproportionate impact on the Black community in New York City’s neighborhoods.

GLP-1 receptor agonists were initially approved for glycaemic control in type 2 diabetes and, subsequently, for bodyweight loss in obesity. Following large-scale trials demonstrating that some GLP-1 ...

Dr. Akshay Jain MD, FRCPC, FACE, CCD, ECNU, DABIM, DABOM, Clinical and Research Endocrinologist, talks about novel medications for diabetes that offer cardiovascular protection.

They keep salad dressing from separating, ice cream from dripping and muffins from hardening. Emulsifiers, used to improve ...